|
Stephanie Wheeler has been a partner in the Firm s Litigation Group since 2003. She has a broad litigation practice that includes civil litigation and white collar and regulatory investigations. Ms. Wheeler s civil litigation practice focuses on complex securities, antitrust, intellectual property and commercial litigation. She has represented Goldman Sachs, JPMorgan Chase, Bank of New York and Vodafone Group Plc in securities class actions and shareholder derivative litigation. Ms. Wheeler also has extensive experience representing clients in criminal and regulatory investigations. She has represented clients in investigations and proceedings before the Securities and Exchange Commission, the NASD, the New York Stock Exchange, the Federal Reserve Bank, the FDIC, the Department of Justice and several State Attorneys General. Selected Cases Represented Goldman Sachs in an industry-wide investigation and global settlement with SEC, NASD, NYSE and 50 state Attorneys General relating to alleged conflicts of interest involving research analysts. Also serves as counsel to Goldman Sachs in related securities class action litigations. Served as a trial lawyer defending Microsoft Corporation in the landmark antitrust trials brought by the U.S. Department of Justice and 19 states and the District of Columbia. Also represented Microsoft in a related antitrust investigation before the European Commission. Represented the Board of JPMorgan Chase in a shareholder derivative action relating to Enron, Worldcom and other matters that alleged wrongful refusal of demand. Achieved dismissal of the complaint with prejudice. Also represented the Board of JPMorgan Chase in the investigation relating to the shareholder demand. Lead counsel to Pershing LLC in market timing investigations by the SEC, NASD and the New York Attorney General. Also lead counsel to Pershing in related multi-district litigation, achieving the dismissal of Pershing from several securities class action lawsuits. Represents Novo Nordisk A/S, a Danish pharmaceutical company, in a patent infringement action against Pfizer Inc. relating to inhalable insulin device. Also successfully defended Novo Nordisk Inc. against a preliminary injunction brought by Sanofi-Aventis under the Lanham Act. Represented Archipelago Holdings in litigation brought by seatholders of the New York Stock Exchange who sought to enjoin the merger of the exchanges. Represented companies in several insider trading investigations. No charges were brought against the companies or any of their employees. Represented a prominent law firm in an investigation brought by regulators for alleged false statements made in connection with a client s regulatory submissions. No charges were brought against the law firm or any of its partners. Professional Activities New York County Lawyers' Association Board Member Legal Momentum Member of President s Council Rankings and Recognition New York Super Lawyers Recognized as a leading securities litigator (July 2006) Practices Antitrust Criminal Defense and Investigations Financial Institutions Intellectual Property and Technology Litigation Securities Litigation Education 1993, Harvard Law School, J.D. 1990, University of Virginia, B.A. Bar Admissions New York Clerkships The Honorable John C. Lifland, United States District Court D., N.J., 1993 - 1994 Country of Origin USA | 